Object-Oriented Approach of Bounded Predictable (BP) Task Scheduler

Haesun K. Lee,Ilhyun Lee,N. Debnath

Abstract:

What problem does this paper attempt to address?

Metastasis of the Mucionous adenocarcinoma of breast to the mandibular gingiva: Rare case report

Ivana Mijatov,Aleksandra Fejsa Levakov,Aleksandar Spasić,Jelena Nikolić,Saša Mijatov

DOI: https://doi.org/10.1097/MD.0000000000030732

2022-09-23

Abstract:Introduction: Mucinous adenocarcinoma (MAC) is a rare type of cancer in which more than 50% of the tumor is composed of extracellular mucin and malignant epithelial cells. MACs account for only 1.8% of all breast cancer cases. Most breast cancers present as localized diseases and are well-differentiated. Breast MAC has a better 5- and 10-year survival rate than ductal and lobular carcinomas. Distant metastasis in breast MAC is rare, especially in the oral cavity. Only 1% of all oral malignancies present with metastases to the oral cavity. The bony structures are more involved than the soft tissues. Involvement of the oral soft tissue is rare, accounting for less than 0.1% of oral metastases. Case description: This report describes a rare case of mucinous breast adenocarcinoma with metastasis to the mandibular molar region. Diagnosis was established based on anamnesis, clinical presentation, tumor biopsy, computed tomography, mammography, and core biopsy of the breast tumor. The patient was sent to the oncology committee for breast disease where chemotherapy was indicated. Discussion: The clinical presentation of oral metastasis is not pathognomonic, and pyogenic granuloma, periodontal abscesses, sarcomas, and squamous carcinoma must be considered in the differential diagnosis. This is a rare case of oral metastasis of breast MAC, which was indicated for detection of the primary tumor.
Malignant Granular Cell Tumor with Breast Metastasis: A Case Report and Review of the Literature

Jida Chen,Linbo Wang,Jing Xu,Tao Pan,Jianguo Shen,Wenqing Hu,Xiaoming Yuan

DOI: https://doi.org/10.3892/ol.2012.702

2012-01-01

Oncology Letters

Abstract:Malignant granular cell tumors (MGCT) are rare mesenchymal soft tissue neoplasms of Schwann cell origin without adequate follow-up. This study describes a case of MGCT with right breast metastasis following two local recurrences. The patient consented to a right breast lumpectomy with right axillary dissection, a right abdominal wall lumpectomy and a right inguinal lumpectomy with dissection. Pathological examination revealed that the two initial lesions were consistent with benign histological performance. The later lesions were classified as malignant due to the observation of spindling of the tumor cells, vesicular nuclei with large nucleoli and increased mitotic rate. Immunohistochemical study of the lesions revealed positivity for S100 protein. The Ki-67 proliferation index increased from 1 to 10%. Twenty-seven months after surgery, the patient was in good health with no sign of further tumor development. We recommend wide local excision with regional lymph node dissection as the first choice of treatment for MGCT.
Primary mucinous cystadenocarcinoma of the breast: A case report and literature review

Xi Cao,Yongchao Luo,Songjie Shen,Xinyu Ren

DOI: https://doi.org/10.3892/ol.2024.14806

2024-11-24

Oncology Letters

Abstract:Mucinous cystadenocarcinoma (MCA) is a rare breast cancer. The present study reports a case of primary MCA of the breast with a comprehensive evaluation of this rare tumour. A 51‐year‐old woman sought medical attention for a mass in the left breast. A core needle biopsy revealed an infiltrating adenocarcinoma with mucus secretion and papillary formation. The macroscopic appearance was of a greyish‐white, tough and well‐circumscribed solid mass, without a notable cyst. Microscopically, the tumour consisted of ducts and cysts of varying sizes. Varying degrees of branching papillary structures were observed in the lumen and cyst cavities. The tumour cells were highly columnar in shape, with high‐grade nuclei arranged in a single‐layer. Immunohistochemistry revealed that the tumour was a basal‐like triple‐negative breast cancer with a high proliferation index and tumour protein p53 diffuse strong expression. Mutations in breast cancer 1‐associated RING domain 1 ( BARD1 ), kinase domain containing receptor ( KDR ), mucin‐6 ( MUC6 ), tumour protein 53 ( TP53 ) and breast cancer 1‐interacting protein C‐terminal helicase 1 ( BRIP1 ) were identified using DNA analysis. The patient was followed up for 26 months and showed no signs of recurrence or metastasis. In conclusion, the current study presents a case of MCA of breast accompanied by mutations in the BARD1 , KDR , MUC6 , TP53 and BRIP1 genes, with no recurrence after a 26‐month follow‐up. Combining this case with a review of the literature helps us to better understand the clinicopathological and genetic characteristics of MCA, and guide treatment.

oncology
Mucinous Adenocarcinoma of The Lateral Tongue with Benign Clinical Appearance: A Diagnostic Challenge

Dr. Shamim Begam Neduvanchery,Prof Indraneel Bhattacharyya,Dr. Sarah Fitzpatrick,Prof. Mohammed Islam

DOI: https://doi.org/10.1016/j.oooo.2024.04.041

2024-07-14

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:Mucinous adenocarcinoma (MAC) of the tongue is a rare malignancy with few cases reported worldwide. It represents a distinct and heterogeneous subtype of adenocarcinoma characterized by mucin production by the tumor cells. We report a unique case of mucinous adenocarcinoma of the tongue, exhibiting a benign clinical appearance.

dentistry, oral surgery & medicine
Case report: Diagnostic trap: a extremely rare metastatic myoepithelial carcinoma of breast

Shuai Luo,Xiaoxue Tian,Ting Xu

DOI: https://doi.org/10.3389/fonc.2024.1436178

IF: 4.7

2024-10-17

Frontiers in Oncology

Abstract:Background: Myoepithelial carcinoma (MECA) is a malignant tumor primarily affecting the salivary gland, most frequently in the parotid gland. It can manifest as primary or secondary to pleomorphic adenoma or benign myoepithelioma. MECA exhibits aggressive behaviors. In particular, primary MECA is more aggressive, frequently recurring or metastasizing distantly. Its morphological and immunohistochemical characteristics overlap with various tumors, posing challenges in its recognization as a distinct entity. Consequently, MECA may be frequently misdiagnosed, mainly when occurred in the mammary gland. This chance for misdiagnosis poses significant challenges in clinical diagnosis and treatment. Case demonstration: A 77-year-old woman with a history of pleomorphic adenoma presented with a palpable lump in the right breast for 3 months. Subsequent core needle biopsy (CNB) and modified radical mastectomy were performed, with samples subjected to histopathological examination. Based on the patient's history, histomorphologic features, immunohistochemistry (IHC) results and results of FISH, the pathological diagnosis confirmed MECA in the mammary gland. Postoperative chemotherapy was administered, and the patient exhibited a favorable prognosis during a 40-month follow-up period. Conclusions: Primary MECA in the mammary gland is exceedingly rare, metastasis from the salivary gland MECA to the mammary gland is even rarer and has not been previously reported. This study presents the first documented case of MECA originating from the parotid gland metastasizing to the mammary gland (also known as breast). Highlighting this case aims to raise awareness among clinical pathologists to prevent underdiagnosis and misdiagnosis of this tumor entity.

oncology
Parotid gland MALT lymphoma with amyloid deposition, challenges in preoperative diagnosis: A case report

Yuriko Watanabe,Hiroyuki Fujii,Saki Yamamoto,Sota Masuoka,Ryoma Kobayashi,Nana Fujii,Akihiro Nakamata,Takeharu Kanazawa,Mitsuru Matsuki,Harushi Mori

DOI: https://doi.org/10.1016/j.radcr.2024.09.083

2024-09-23

Abstract:Mucosa-associated lymphoid tissue (MALT) lymphoma commonly arises from chronic inflammation or autoimmune diseases, such as Sjögren syndrome (SjS). Although rare, amyloid deposition in MALT lymphoma has been reported. We present a rare case of parotid gland MALT lymphoma in a 49-year-old woman, in whom preoperative diagnosis was challenging due to atypical imaging findings resulting from amyloid deposits. MRI showed T2-hypointense and T1-iso- to slightly hyperintense masses in the left parotid gland and right sublingual gland, with predominant marginal contrast enhancement and no significant diffusion restriction. Additionally, atrophy and fatty replacement of the parenchyma were noted in bilateral parotid glands, suggesting SjS. Left superficial parotidectomy was performed and pathological findings confirmed MALT lymphoma with extensive amyloid deposition. Histopathological findings of the resected parotid gland parenchyma also suggested SjS. MALT lymphoma should be considered in the differential diagnosis of multiple salivary gland masses in patients with suspected SjS. If MRI reveals atypical imaging findings for malignant lymphoma, particularly T2-hypointensity with no significant diffusion restriction, the possibility of amyloid deposition in MALT lymphoma should be considered.
A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients

L. Federici,C. Rittore-Domingo,I. Koné-Paut,Christian Jorgensen,Michel Rodière,A. Quellec,I. Touitou

DOI: https://doi.org/10.1136/ard.2006.054304

IF: 27.973

2006-05-17

Annals of the Rheumatic Diseases

Abstract:Background: The diagnostic value of molecular analysis of the familial Mediterranean fever (FMF) gene (Mediterranean fever (MEFV)) has been well established only in patients selected on the basis of ethnic background or clinical criteria. Genetic diagnosis for other hereditary periodic fever syndromes has been poorly evaluated. Objective: To determine the diagnostic contribution of genetic tests for hereditary periodic syndromes in a large, unselected series of patients. Methods: A retrospective study was conducted on 1941 patients referred to us for FMF genetic tests between 1997 and 2005. MEFV genotypes were compared with clinical data to appraise criteria for FMF diagnosis. Genetic tests for tumour necrosis factor receptor-associated periodic syndrome (TRAPS), hyperimmunoglobulinaemia D syndrome (HIDS) and cryopyrin-associated periodic syndromes (CAPS) were also reviewed. Results: 71% of the 1574 patients with enough data had a clinical diagnosis of FMF according to the widely used Israeli criteria. Two MEFV mutations were found in only 409 patients of this subgroup (sensitivity = 37%) and in 15 (3.3%) of the patients with an improbable clinical diagnosis of FMF (specificity = 97%). Molecular diagnosis for alternate hereditary periodic syndromes was carried out in 456 of the patients having a non-conclusive FMF genetic test. A positive diagnosis was obtained in 31 of these patients (TRAPS (n = 19), HIDS (n = 4) and CAPS (n = 8)). Conclusions: First-line MEFV mutation screening in patients with clinically typical FMF may be appropriate only in particular areas. To optimise genetic diagnosis, we propose a decision tree, which, with the advice of an expert practitioner, could help redirect test indications towards non-FMF hereditary periodic syndromes.
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review.

Ying Gong,Xuhua Geng,Yaxin Liu,Ruyan Zhang,Yiqiang Liu,Huiping Li

DOI: https://doi.org/10.1159/000535649

2024-01-01

Oncology Research and Treatment

Abstract:INTRODUCTION:Mucinous cystadenocarcinoma (MCA) of the breast is an extremely rare type of breast carcinoma. Since its biological characteristics, treatment options, and clinical outcomes are unclear, there is a lack of consensus regarding the optimal management of this disease. Thus, our single case report will aid our understanding of its natural history, prognostic factors, and treatment strategies.CASE PRESENTATION:We presented a 54-year-old woman with a case of advanced MCA of the breast accompanied by a huge breast mass, lymph node involvement, and distant bone metastases. We diagnosed primary breast MCA through clinical examination, imaging, and immunohistochemical assessments. Subsequently, the patient was treated with a regimen of nab-paclitaxel and bevacizumab, resulting in a significant clinical response. Progression-free survival was maintained during the 6-month follow-up period.CONCLUSION:We present the first report worldwide of a rare case of MCA of the breast with a large local mass and bone metastases. Our report adds to the limited literature on this rare breast cancer subtype and highlights the importance of accurate diagnosis and appropriate management of aggressive breast tumors.
Mammary analogue secretory carcinoma involving submandibular gland: Diagnostic pitfall with review of literature

Nimisha Dhankar,Nidhi Verma,Abhinav Agarwal,Ravi Mehar,Sunil Pasricha

DOI: https://doi.org/10.4103/jcrt.jcrt_2148_22

2024-07-01

Abstract:Mammary analogue secretory carcinoma (MASC) is a recently defined entity among salivary gland tumors. MASC bores a striking resemblance to secretory carcinoma of breast along with the characteristics of ETV6-NTRK3 translocation. Hence, the entity was designated as MASC and was formally included in the 4th edition of World Health Organization classification of head and neck tumors in 2017. To the best of our knowledge, around 12 cases of MASC have been described in the Indian literature. MASC commonly involves parotid gland (70%). Involvement of submandibular gland is still rarer (7%). Prognosis of MASC is comparable to other low grade salivary gland malignancies; however, aggressive behavior has also been reported in few cases. This case is one of the very few reported cases describing MASC with detailed clinical, cytology, and microscopy findings along with special stains and immunohistochemistry.
Unmasking the rarity of mammary analogue secretory carcinoma of the minor salivary gland - A case report

Samkit V Sakhariya,Anuja Chincholkar,Sanika Tidke,Sneha Setiya,Noopur Mane,Megha Markand

DOI: https://doi.org/10.1016/j.ijscr.2024.110374

Abstract:Introduction: Mammary analogue secretory carcinoma (MASC) of the salivary gland was first described by Skálová et al. in 2010. It is often associated with a translocation, t(12;15)(p13;q25), which results in the fusion gene ETV6-NTRK3. Major salivary glands, primarily the parotid gland, are involved in 70 % of cases of MASC, while small salivary glands are involved in less than 25 % of cases. This report aims to consolidate in unveiling, diagnosing, and managing the rarity of MASC in the minor salivary gland and its existing knowledge and encourage new research on this increasingly important salivary gland malignancy. Presentation of the case: A 27-year-old female reported with a complaint of swelling on the right cheek region of face since 10 weeks. On bimanual palpation, a soft lobulated mass was appreciated beneath the healthy mucosal layer. The radiographic image (orthopantomogram) showed no obvious calcified mass. An excisional biopsy was planned and performed under local anesthesia. Microscopic and immunohistochemistry confirmed the tumor to be a MASC of minor salivary gland. Discussion: Due to their infrequency and multiplicity of histopathology, MASC presents difficulty in diagnosis. A key to determining diagnostic criteria for MASC is to study cellular morphology, cytoplasmic filament expression, and ultrastructural features of the tumor and apply this information to defining MASC. Conclusion: MASC is an important molecularly defined entity of the salivary gland with low-grade malignant potential. Correct diagnosis is essential for appropriate treatment and will help to provide better information about this potentially low-grade malignant salivary gland neoplasm.
Cytopathology of a newly described salivary gland neoplasm. A case report of microsecretory adenocarcinoma presenting in the parotid gland.

Rubina Razack,Justin A. Bishop,Julandi Alwan,Liezel Coetzee,Daniel Rudolph De Wet,Wasim Mahomed,Marc Merven,Pawel Tomasz Schubert,Amir Afrogheh

DOI: https://doi.org/10.1159/000541997

2024-10-14

Acta Cytologica

Abstract:Introduction: Microsecretory adenocarcinoma (MSA) is a novel entity defined by distinctive histology, a specific immunophenotype, and unique molecular fusion MEF2C::SS18. It occurs mainly in intra-oral minor salivary glands and the skin, with only one reported case affecting the parotid gland. To the best of our knowledge, no cytomorphological features of MSA have been published. We report the first case of fine needle aspiration biopsy (FNAB) cytology of MSA diagnosed in the parotid gland. Case Presentation: A 48-year-old man presented with a 3.5 x 2.5 cm parotid mass. FNAB of the tumor revealed a cellular smear comprising a predominantly epithelial cell population showing luminal differentiation with secretory features and a distinctive background matrix with both myxoid and mucinous qualities. Scattered, but conspicuous multinucleated giant cells were present, a feature not commonly observed in salivary gland aspirates. Histology of the excised tumor revealed classic features of MSA with supportive immunohistochemistry and SS18 break-apart fusion detected by fluorescence in situ hybridization (FISH). Next-generation sequencing confirmed a MEF2C::SS18 gene fusion. Conclusion. MSA is a rare neoplasm and should be considered in the cytological differential diagnosis of low-grade salivary gland neoplasms. Its unique cytomorphological features should raise the possibility of MSA in salivary gland FNABs. The diagnosis can be established on cellular cell block preparations using immunohistochemistry and FISH or PCR.

pathology
Basal cell adenoma of the deep lobe of the parotid gland misdiagnosed as mucoepidermoid carcinoma - A case report

Neemu Hage,R Balaji,Namit Kant Singh,Sumitra Sivakoti,Somalwar B Shrinivas

DOI: https://doi.org/10.1016/j.ijscr.2024.110218

2024-08-28

Abstract:Introduction: Basal cell adenoma is a rare, benign epithelial tumour of the salivary gland, comprising only 1-2 % of all salivary gland tumours. Predominantly found in the parotid gland, basal cell adenoma can also occur in minor salivary glands and are often confused with other benign and malignant salivary gland tumours. A thorough histopathological examination can provide a definitive diagnosis. Presentation of case: A 65-year-old woman presented with a painless mass in the right infra-auricular region. Imaging revealed a well-defined hypodense lesion in the deep lobe of the right parotid gland, initially suspected as mucoepidermoid carcinoma. Fine needle aspiration was inconclusive, leading to the decision to perform a total conservative parotidectomy. Histopathology confirmed basal cell adenoma, characterized by cystic areas filled with mucoid material and basaloid cells arranged in trabecular and tubular patterns. Discussion: Basal cell adenoma was classified as a distinct entity by the WHO in 1991. Cytologically, they imitate both benign and malignant salivary as well as non-salivary gland tumours. The histological hallmark of basal cell adenoma involves basaloid cells with small round nuclei showing no atypia, scant pale cytoplasm, and distinct peripheral palisading. Treatment involves surgical removal, with a more radical approach for certain variants such as the membranous type. Conclusion: This case highlights the clinical, radiological, and histopathological features of basal cell adenoma, emphasizing the importance of accurate diagnosis and appropriate surgical management. Early detection and appropriate treatment are crucial for optimizing patient outcomes in basal cell adenoma management.
Case report: Metastatic ovarian mucinous carcinoma to the breast: diagnostic challenges and pitfalls

Natthawadee Laokulrath,Siew Kuan Lim,Hwee Yong Lim,Mihir Gudi,Puay Hoon Tan

DOI: https://doi.org/10.3389/fonc.2024.1364011

IF: 4.7

2024-03-18

Frontiers in Oncology

Abstract:Metastases to the breast from extramammary sources are extremely rare, with the ovary, primarily high-grade serous carcinoma, being the most common origin. We report a case of breast metastases from advanced stage ovarian mucinous carcinoma in a 48-year-old female— a case hitherto unreported in the literature. The case is noteworthy for its atypical presentation marked by an areolar rash, clinically suggestive of Paget disease of the nipple. This unique clinical scenario, coupled with histopathological examination revealing in-situ -like carcinoma component, posed a diagnostic challenge in discerning the tumour origin. We emphasize the need for heightened awareness among pathologists to avoid misdiagnosing metastatic carcinomas as primary breast tumours, a potential pitfall with significant clinical implications.

oncology
HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature

Ismail Guzelis,Betul Bolat Kucukzeybek,Mehmet Ali Uyaroglu,Melek Bekler Gokova,Gulten Sezgin,Yuksel Kucukzeybek

DOI: https://doi.org/10.1002/dc.25364

2024-06-05

Diagnostic Cytopathology

Abstract:Primary mucinous cystadenocarcinoma (MCA) of the breast is a rare variant of breast carcinoma. A 68‐year‐old female patient presented to the general surgery clinic with pain and swelling in the right breast. A mass was detected in the upper outer quadrant, and a fine‐needle aspiration biopsy was performed. The May‐Grünwald Giemsa stained slides showed aggregates of mucin‐rich pleomorphic cells with large nuclei in a mucinous background containing discohesive single cells. The Papanicolaou stain revealed a papillary structure composed of malignant epithelial cells in a necrotic background. A modified radical mastectomy was performed, and upon gross examination, two tumors were discovered in the central and upper outer quadrants. The first tumor, located centrally, was identified as invasive lobular breast carcinoma. The second tumor was an MCA with cytokeratin 7(+) and cytokeratin 20(−), and was determined to be the primary MCA of the breast based on clinical and radiological information. Immunohistochemistry revealed that the tumor cells were negative for estrogen receptor and progesterone receptor, and HER2 was 2+. Fluorescence in situ hybridization analysis detected HER2 gene amplification. During the 72‐month follow‐up, there were no findings compatible with recurrence or new metastasis. Although primary MCA is rare, it causes differential diagnosis problems and has different biological behaviors.

pathology,medical laboratory technology
Invasive Breast Carcinoma Arising in Microglandular Adenosis: A Case Report and Review of the Literature

Ruohong Shui,Wentao Yang

DOI: https://doi.org/10.1111/j.1524-4741.2009.00839.x

2009-01-01

Abstract:Microglandular adenosis of the breast is an extremely rare, benign lesion. Carcinoma arising in microglandular adenosis has been reported in up to 27% of patients with microglandular adenosis. We reported a case of invasive carcinoma arising in microglandular adenosis. A lumpectomy was performed on a 42-year-old female because of a mass in the right breast. Grossly, the lesion was ill-defined with thickened areas. Histologically, this case was consistent with carcinoma arising in microglandular adenosis and showed clear transition from microglandular adenosis through atypical microglandular adenosis to in situ and invasive carcinoma. All the epithelial cells were positive for cytokeratin7, S-100 protein, but negative for estrogen receptor, progesterone receptor, and Her2/Neu. No myoepithelial cells were demonstrable with immunohistochemical staining for smooth muscle actin, muscle-specific antigen or P63. Periodic acid-Schiff staining showed the presence of a basement membrane in microglandular adenosis, atypical microglandular adenosis, in situ carcinoma and the absence in invasive carcinoma. To the best of our knowledge, this is the first reported case of carcinoma arising in microglandular adenosis in China.
The fusimotor activity and natural sleep in the cat.

K. Kubota,R. Tanaka

DOI: https://doi.org/10.1016/0006-8993(66)90078-3

IF: 3.61

1966-12-01

Brain Research

Abstract:
Macrocystic secretory carcinoma arising from the buccal minor salivary gland clinically mimicking a mucocele: A case report

Tadashi Chida,Akari Teramoto-Nagae,Yu Usami,Katsutoshi Hirose,Satoko Kishimoto,Ken Wakabayashi,Tomohiko Kanesaki,Yoshihiro Morita,Narikazu Uzawa

DOI: https://doi.org/10.3892/ol.2024.14626

2024-08-12

Abstract:Secretory carcinoma (SC) is an uncommon salivary gland tumor that has been recently conceptualized. The present report describes a case of SC that was diagnosed as a mucocele on preoperative examination. A 46-year-old man presented to the Department of Oral and Maxillofacial Surgery at Saiseikai Senri Hospital (Suita-shi, Japan) with a main complaint of swelling of the right buccal mucosa. A mobile, elastic, hard mass was found beneath the right normal-appearing buccal mucosa. T2-weighted magnetic resonance imaging revealed a well-defined, internally homogeneous high-signal area with a maximum diameter of 18 mm. Based on the clinical diagnosis of mucocele, the buccal lesion was excised. Histopathological, immunohistochemical and fluorescence in situ hybridization analyses revealed the cystic lesion to be a macrocystic SC of a minor salivary gland. SC may have a mucocele-like appearance on magnetic resonance imaging. Even if a non-neoplastic lesion is suspected, the possibility of a malignant lesion such as SC must be considered for salivary gland disease.
Metastatic Intestinal Adenocarcinoma: A Rare Case Involving the Mandible

Baishakhi Modak,Chetana Chandrashekar,Adarsh Kudva,Raghu Radhakrishnan

DOI: https://doi.org/10.1007/s12105-024-01697-4

2024-09-30

Abstract:Background: Metastatic intestinal adenocarcinoma involving the mandible is rare, posing diagnostic challenges because of its unusual presentation. Case presentation: A 55-year-old male presented with a rapidly growing mass in the right mandible, accompanied by facial asymmetry and vestibular obliteration. Histopathological examinations revealed features consistent with adenocarcinoma. Immunohistochemical analysis supported the diagnosis of intestinal adenocarcinoma, with subsequent metastasis confirmed by PET scan findings. Diagnosis: The lesion was conclusively diagnosed as intestinal adenocarcinoma metastasizing to the mandible. Management: The patient pursued treatment at a government facility, leading to a loss of follow-up.
An Extracranial Metastasis of Glioblastoma Mimicking Mucoepidermoid Carcinoma.

Weiping Jie,Jiaying Bai,Binbin Li

DOI: https://doi.org/10.1016/j.wneu.2018.05.132

IF: 2.21

2018-01-01

World Neurosurgery

Abstract:BACKGROUND: Glioblastoma (GBM) is the most common and aggressive primary malignant tumor of the brain and central nervous system. Extracranial metastases of GBM are rare, with few case reports published to date. The tumor cells of GBM show strong immunopositivity for glial fibrillary acid protein. CASE DESCRIPTION: A 47-year-old man without comorbidities presented with a 1-year history of an augmenting right parotid lump. A right total parotidectomy with selective neck dissection was performed. The hematoxyline eosin-stained slice of a parotid lymph node collected intraoperatively revealed destruction of normal lymph node structure by medium-sized pleomorphic cells scattered in groups; their cytoplasm was lightly stained and pale. There were abundant myxoid stroma in the interstitial tissue. This characteristic mimicked mucoepidermoid carcinoma. An immunohistochemistry test demonstrated that the tumor cells were positive for glial fibrillary acid protein. A diagnosis of extracranial metastasis of GBM was made after confirmation with postoperative pathologic examination and the review of the intracranial resection specimen. CONCLUSIONS: We believe that this is the first reported case of extracranial metastasis of GBM resembling mucoepidermoid carcinoma in the microscope features. Pathologists and clinicians should be alert to this rare lesion and consider this differential diagnosis after excluding other common parotid lesions.
Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer

An Huang,Yong Yang,Jing-Yi Shi,Yu-Kun Li,Jing-Xuan Xu,Yu Cheng,Jin Gu

DOI: https://doi.org/10.4240/wjgs.v13.i12.1567

2021-12-27

World J Gastrointest Surg

Abstract:Mucinous adenocarcinoma (MAC) is a unique clinicopathological subtype of colorectal cancer, which is characterized by extracellular mucinous components that comprise at least 50% of the tumor tissue. The clinical characteristics, molecular features, response to chemo-/radiotherapy, and prognosis of MAC are different from that of non-MAC (NMAC). MAC is more common in the proximal colon, with larger volume, higher T-stage, a higher proportion of positive lymph nodes, poorer tumor differentiation, and a higher proportion of peritoneal implants compared to NMAC. Although biopsy is the main diagnostic method for MAC, magnetic resonance imaging is superior in accuracy, especially for rectal carcinoma. The aberrant expression of mucins, including MUC1, MUC2 and MUC5AC, is a notable feature of MAC, which may be related to tumor invasion, metastasis, inhibition of apoptosis, and chemo-/radiotherapy resistance. The genetic origin of MAC is mainly related to BRAF mutation, microsatellite instability, and the CpG island methylator phenotype pathway. In addition, the poor prognosis of rectal MAC has been confirmed by various studies, and that of colonic MAC is still controversial. In this review, we summarize the epidemiology, clinicopathological characteristics, molecular features, methods of diagnosis, and treatments of MAC in order to provide references for further fundamental and clinical research.

Object-Oriented Approach of Bounded Predictable (BP) Task Scheduler

Metastasis of the Mucionous adenocarcinoma of breast to the mandibular gingiva: Rare case report

Malignant Granular Cell Tumor with Breast Metastasis: A Case Report and Review of the Literature

Primary mucinous cystadenocarcinoma of the breast: A case report and literature review

Mucinous Adenocarcinoma of The Lateral Tongue with Benign Clinical Appearance: A Diagnostic Challenge

Case report: Diagnostic trap: a extremely rare metastatic myoepithelial carcinoma of breast

Parotid gland MALT lymphoma with amyloid deposition, challenges in preoperative diagnosis: A case report

A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients

Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review.

Mammary analogue secretory carcinoma involving submandibular gland: Diagnostic pitfall with review of literature

Unmasking the rarity of mammary analogue secretory carcinoma of the minor salivary gland - A case report

Cytopathology of a newly described salivary gland neoplasm. A case report of microsecretory adenocarcinoma presenting in the parotid gland.

Basal cell adenoma of the deep lobe of the parotid gland misdiagnosed as mucoepidermoid carcinoma - A case report

Case report: Metastatic ovarian mucinous carcinoma to the breast: diagnostic challenges and pitfalls

HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature

Invasive Breast Carcinoma Arising in Microglandular Adenosis: A Case Report and Review of the Literature

The fusimotor activity and natural sleep in the cat.

Macrocystic secretory carcinoma arising from the buccal minor salivary gland clinically mimicking a mucocele: A case report

Metastatic Intestinal Adenocarcinoma: A Rare Case Involving the Mandible

An Extracranial Metastasis of Glioblastoma Mimicking Mucoepidermoid Carcinoma.

Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer